Softwr

Healthcare · head to head

Rx30 vs Visage Imaging

Rx30 logo

Rx30

Healthcare

Long-established pharmacy management system for independents and small chains

From
On request
Rated
-
Visage Imaging logo

Visage Imaging

Healthcare

Server-side streaming PACS built for radiologists reading very large studies over thin connections

From
On request
Rated
-

The short version

  • Each has a real cost: Rx30 shares ownership with PioneerRx, so the two are not the independent alternatives a shortlist implies, and roadmap priorities are set centrally; Visage Imaging pricing is per exam against a minimum annual volume, so an organisation whose imaging activity is flat pays a floor while a growing one sees the software line rise every year rather than amortise.
  • They diverge on capability: Rx30 covers Prescription processing, Visage Imaging covers Server-side rendering.
  • Prices and features above were last checked on 1 September 2026.

Where they differ

Only the attributes on which Rx30 and Visage Imaging actually diverge.

Attributes where Rx30 and Visage Imaging differ
AttributeRx30Visage Imaging
PlatformsWindows, WebWindows, macOS, Web, iOS, Cloud

Identical on both: starting price (On request), pricing model (quote), free tier (No), user rating (Not yet rated), category (Healthcare).

What each one covers

Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in Rx30

  • Prescription processing
  • Claims adjudication
  • Inventory and purchasing
  • Point of sale
  • Delivery management
  • Clinical documentation

Only in Visage Imaging

  • Server-side rendering
  • One Viewer
  • Native multi-dimensional tools
  • Digital breast tomosynthesis reading
  • Open archive
  • Cloud PACS operations
  • AI accelerator
  • On the fly patient jacket

What people use each for

The jobs each tool is most often brought in to do.

Rx30

  • Independent pharmacies and small chains wanting a mature, widely-supported systemnot Visage Imaging
  • Operations relying on a broad set of wholesaler and PBM interfacesnot Visage Imaging
  • Pharmacies with significant front-end retail alongside dispensingnot Visage Imaging
  • Multi-store independents needing consistency across locationsnot Visage Imaging

Visage Imaging

  • An academic health system whose radiologists read from home and cannot tolerate a thousand slice CT taking minutes to opennot Rx30
  • A breast imaging service moving to tomosynthesis where study sizes have made the existing PACS unusable at volumenot Rx30
  • A teleradiology group covering many client sites that needs one viewer rather than a client-specific workstation per contractnot Rx30
  • A health system mid migration that needs priors from three legacy archives assembled into one patient jacket before the data move finishesnot Rx30

Where each one falls short

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

Rx30

  • Shares ownership with PioneerRx, so the two are not the independent alternatives a shortlist implies, and roadmap priorities are set centrally
  • The interface shows its age against newer entrants, and this is the most common objection in demonstrations
  • Pricing is not published, and total cost including hardware and interfaces needs to be requested explicitly
  • Windows-centric, with a cloud story less developed than newer competitors
  • US-only, tied to US insurance and regulatory requirements

Visage Imaging

  • Pricing is per exam against a minimum annual volume, so an organisation whose imaging activity is flat pays a floor while a growing one sees the software line rise every year rather than amortise.
  • Module breadth outside radiology is narrower than at Sectra or the large modality vendors, so a group planning to digitise pathology on the same platform will not find it here.
  • Server-side rendering shifts the cost to central infrastructure, so the saving on radiologist workstations is partly offset by what you spend on servers or cloud compute.
  • Pro Medicus concentrates on very large contracts, and smaller imaging groups report long sales cycles and little appetite from the vendor for deals below a certain volume.
  • Diagnostic AI is third party, surfaced through the accelerator framework rather than developed in house, so algorithm licensing, validation and monitoring remain the buyer problem.

Pricing, plan by plan

Rx30

On request
  • Rx30$undefined/month
    • Prescription processing
    • Claims adjudication
    • Inventory

Visage Imaging

On request
  • Visage 7 enterprise contract$undefined/year
    • Transaction pricing per exam with a minimum annual volume commitment
    • Seven to ten year terms typical for health system contracts
    • Contract totals for major deals are disclosed by Pro Medicus to the ASX

Which should you pick?

Choose Rx30 if

  • You need prescription processing.
  • You work on Windows, Web.
  • You also want claims adjudication.

Choose Visage Imaging if

  • You need server-side rendering.
  • You work on Windows, macOS, Web, iOS, Cloud.
  • You also want one viewer.

Questions people ask

Is Rx30 or Visage Imaging better?
Neither clearly leads. Rx30 starts at On request and Visage Imaging at On request, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, Rx30 or Visage Imaging?
Rx30 starts at On request and Visage Imaging at On request.
Does Rx30 or Visage Imaging run on more platforms?
Rx30 runs on Windows, Web. Visage Imaging runs on Windows, macOS, Web, iOS, Cloud.
What is Rx30 best used for?
Rx30 is most often used for independent pharmacies and small chains wanting a mature, widely-supported system, operations relying on a broad set of wholesaler and pbm interfaces, pharmacies with significant front-end retail alongside dispensing, multi-store independents needing consistency across locations. Of those, independent pharmacies and small chains wanting a mature, widely-supported system and operations relying on a broad set of wholesaler and pbm interfaces are not what Visage Imaging is typically brought in for.
What can Rx30 do that Visage Imaging cannot?
Rx30 covers Prescription processing, Claims adjudication, Inventory and purchasing, Point of sale. Visage Imaging covers Server-side rendering, One Viewer, Native multi-dimensional tools, Digital breast tomosynthesis reading.

Answered from the vendors’ own pages

Rx30: Is Rx30 the same company as PioneerRx?

Both are owned by RedSail Technologies. They are sold as separate products to overlapping markets, but roadmap decisions sit with one company, which is worth knowing before treating them as independent options.

Visage Imaging: Who owns Visage Imaging?

Pro Medicus Limited, listed on the Australian Securities Exchange. That listing means major contract values and terms are publicly announced.

Rx30: What does it cost?

Not published. Request the total including hardware, interfaces and training rather than the monthly software fee.

Visage Imaging: How is Visage priced?

Per exam, against a minimum annual volume, on multi-year terms. Because Pro Medicus discloses large contract totals and durations to the market, buyers can estimate a per exam rate before entering negotiation.

Rx30: Why do pharmacies stay on it?

Installed base maturity. The interfaces to wholesalers, PBMs and hardware are long established, and those are the things that quietly stop a pharmacy working when they break.

Visage Imaging: Is Visage 7 FDA cleared for diagnostic interpretation?

Yes, Visage 7 holds 510(k) clearance for diagnostic viewing including mammography and tomosynthesis on validated displays. Confirm the exact cleared modality list for your intended use.

Rx30: How does it compare to PioneerRx?

PioneerRx is more aggressively developed around clinical services. Rx30 has the larger legacy base and broader front-end retail heritage. Same owner, different emphasis.

Visage Imaging: Does it work as a full cloud PACS?

Yes, Visage 7 runs complete PACS operations in the cloud rather than cloud viewing over an on-premise archive.

Rx30: Is it suitable for a small chain?

Yes, and that is one of its stronger cases. Multi-store consistency is better handled here than by the systems aimed purely at single independents.

Share

Related pages

Other head to heads